{
  "ticker": "NAMS",
  "success": true,
  "price": {
    "current": 31.44,
    "currency": "USD",
    "day_high": 32.275,
    "day_low": 31.26,
    "52_week_high": 42.0,
    "52_week_low": 14.06
  },
  "market_cap": {
    "value": 3565006848.0,
    "currency": "USD"
  },
  "shares_outstanding": 113390804.0,
  "volume": {
    "last": 320259,
    "average_30d": 733764
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": -18.168072,
    "price_to_book": 4.8873
  },
  "company_info": {
    "name": "NewAmsterdam Pharma Company N.V.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 786427000.0,
    "total_liabilities": 58357000.0,
    "stockholders_equity": 728070000.0,
    "cash": 538407000.0,
    "marketable_securities": 164539000.0,
    "total_liquidity": 702946000.0,
    "total_debt": 266000.0,
    "long_term_debt": 85000.0,
    "current_debt": 181000.0,
    "error": null
  },
  "cash_flow": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_cash_flow": -32769000.0,
    "free_cash_flow": -32811000.0,
    "investing_cash_flow": 2506000.0,
    "financing_cash_flow": 5892000.0,
    "error": null
  },
  "income_statement": {
    "success": true,
    "period_date": "2025-09-30",
    "operating_expense": 55491000.0,
    "research_and_development": 30971000.0,
    "interest_expense": null,
    "net_income": -72005000.0,
    "revenue": 348000.0,
    "gross_profit": null,
    "ebitda": -55079000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true,
    "has_cash_flow": true,
    "has_income_statement": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:49:39.575941",
    "url": "https://finance.yahoo.com/quote/NAMS",
    "data_hash": "1113210520966fe9"
  }
}